Compare SNES & NXGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SNES | NXGL |
|---|---|---|
| Founded | 2004 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Agricultural Chemicals | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.5M | 15.0M |
| IPO Year | 2016 | 2021 |
| Metric | SNES | NXGL |
|---|---|---|
| Price | $2.33 | $1.59 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 36.9K | ★ 81.6K |
| Earning Date | 11-10-2025 | 11-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,301,000.00 | ★ $11,666,000.00 |
| Revenue This Year | $41.52 | $39.28 |
| Revenue Next Year | $77.28 | $42.29 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 39.37 | ★ 73.37 |
| 52 Week Low | $1.30 | $1.45 |
| 52 Week High | $6.24 | $4.95 |
| Indicator | SNES | NXGL |
|---|---|---|
| Relative Strength Index (RSI) | 36.89 | 43.37 |
| Support Level | $2.25 | $1.55 |
| Resistance Level | $2.53 | $1.90 |
| Average True Range (ATR) | 0.19 | 0.16 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 12.50 | 24.57 |
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.